
What We're Reading: HealthCare.gov Maintenance; USMCA Drug Exclusivity; Medicare Telemedicine Proposal
When consumers try to sign up for Affordable Care Act health plans on the federal marketplace, they may encounter hours-long downtime for the site; the United States–Mexico–Canada Agreement would increase pharmaceutical exclusivity from 8 years to 10 years, delay access to competition from biosimilar biologics; Medicare is considering paying for telemedicine for a 5-minute check-in call, but physicians question the proposal.
Administration Plans HealthCare.gov Maintenance During Open Enrollment
When consumers try to sign up for Affordable Care Act health plans on the federal marketplace, they may encounter hours-long downtime for the site.
NAFTA Replacement Could Thwart Biosimilars
The United States—Mexico–Canada Agreement, or USMCA, updates the North American Free Trade Agreement and increase pharmaceutical exclusivity from 8 years to 10 years. The new deal allows US drug companies to sell pharmaceutical products in Canada for 10 years without generic or biosimilar competition,
Physicians Question Medicare’s Proposed Telemedicine Reimbursement
Medicare is considering paying for telemedicine by reimbursing doctors $14 for a 5-minute check-in call with patients. However, many physicians are unhappy that patients would be required to pay a 20% cost-sharing charge.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.